MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from notes
payable
$6,977,822
Proceeds from private
placements
$2,376,181
Net cash provided by
financing activities
$8,382,772
Canceled cashflow
$971,231
Net increase
(decrease) in cash
-$127,767
Canceled cashflow
$8,382,772
Goodwill impairment
$170,419,429
Non-cash stock-based
compensation expense
$3,313,291
Accounts payable
$3,106,181
Non-cash restricted
shares issued for...
$1,946,845
Other receivables
-$1,153,768
Prepaid
expenses/deposits
-$1,143,293
Accrued expenses
$499,330
Depreciation and
amortization
$129,095
Change in fair value of
equity securities
$112,149
Amortization of discount on
note payable
$32,024
Repayments of finance
agreement
$971,231
Net cash used in
operating activities
-$7,874,647
Canceled cashflow
$181,855,405
Net cash used in
investing activities
-$500,000
Effect of exchange
rates on cash
-$135,892
Net loss
-$178,007,489
Change in fair value of
contingent consideration
$11,680,000
Other current
liabilities
-$26,477
Operating leases, net
-$16,086
Investment in equity
securities
$500,000
Back
Back
Cash Flow
source: myfinsight.com
Lunai Bioworks Inc. (RENB)
Lunai Bioworks Inc. (RENB)